Quality Indicator in Pneumonia Mortality Rate - Essay Sample

Pneumonia is highly considered as one of common death which occurs from infection in persons. It is considered to be the fourth most mutual cause of death for individuals over the age of 80 years. According to statistics, it has been approximated that the exact cost of over $9.7 billion is used for the treatment of pneumonia patients (Rhew, 2001). Most of the cost is incurred if the patient is hospitalized. It has existed and approximated that every 962 patients out 100 000 persons who are over 65 years of age are hospitalized due to pneumonia causes annually. It is statistics which is done worldwide and in all nations (Rhew, 2001). Older patients are, therefore, at a higher risk of morbidity and death due to pneumonia. This is a risk to the population of the older generation, which might lead to a substantial reduction in mortality of older generations in the future. The essay will focus on some of the quality indicators (QIs), which are used in the pneumonia mortality rate to address some of the issues expressed, especially with substantial generation.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Order now

The research has considered various and valid quality indicators that support the pneumonia mortality rate worldwide. Most of the consideration of these quality indicators are being expressed and proposed in the United States. The first quality indicator features a pneumococcal vaccine, which is offered to patients even if they have no history of the allergy. It is done purposely to ensure that the elderly are efficacious and can act as preventive measures for elderly patients. Pneumococcal vaccine can reduce the overall incidence, which might be caused by bacteremia, but to some extent, it is not effective for all patients (Uç kay et al., 2008).

The second one is termed as the influenza vaccine; it is operative in limiting some of the Spartan diseases which are currently instigated by the influenza virus. The vaccine is highly operational for elderly patients as it reduces the mortality rate risks. The next is administering pneumococcal and influence vaccination to elderly patients. The vaccinations are offered since the hospitalization provides an opportune moment, which is regarded for administering the vaccine to the patient. There is a need to include methods which can increase the rate of vaccination as it creates an intervention which enhances the protection for both outpatient and inpatient setting in hospitals.

There is influenza vaccination which is administered for health care workers. The vaccination is offered to reduce the mortality rate and another incidence of influenza, which occurs in a patient like frequent illness. Findings have approved that treatment of health workers, especially elderly patients, always reduces the mortality rate. Various nations have considered this as a significant issue related to the influence of mortality rate. The next one for the case of QIs is smoking cessation, where the elderly are advised to quit smoking. Long term cessation related to smoking might lead to the patient developing some recurrent pneumonia and other body complications, especially the elderly. Use of antibiotics has to be administered to the elderly generation within 8 hours of arrival to the hospital as it is associated with lowering of 30-day mortality rate among others (Rhew, 2001). Summary, for the perfect outcome on pneumonia mortality rate, the various QIs have been approved using the evidence-based cases and other formal consensus techniques which has minimized the mortality rate level. Therefore, the future of quality healthcare in the case of pneumonia may be linked with QIs to strengthen most of the patients. It is good to establish comprehensive and standard care which can manage most of the patients.

References

Rhew, D. C. (2001). Quality indicators for the management of pneumonia in vulnerable elders. Annals of Internal Medicine, 135(8_Part_2), 736-743. https://doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00013

Uç kay, I., Ahmed, Q. A., Sax, H., & Pittet, D. (2008). Ventilator-associated pneumonia as a quality indicator for patient safety?. Clinical Infectious Diseases, 46(4), 557-563. https://doi.org/10.1086/526534